Full text
PDFPage 688
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Calvert A. H., Alison D. L., Harland S. J., Robinson B. A., Jackman A. L., Jones T. R., Newell D. R., Siddik Z. H., Wiltshaw E., McElwain T. J. A phase I evaluation of the quinazoline antifolate thymidylate synthase inhibitor, N10-propargyl-5,8-dideazafolic acid, CB3717. J Clin Oncol. 1986 Aug;4(8):1245–1252. doi: 10.1200/JCO.1986.4.8.1245. [DOI] [PubMed] [Google Scholar]
- Harding M. J., Cantwell B. M., Milstead R. A., Harris A. L., Kaye S. B. Phase II study of the thymidylate synthetase inhibitor CB3717 (N10-propargyl-5,8-dideazafolic acid) in colorectal cancer. Br J Cancer. 1988 Jun;57(6):628–629. doi: 10.1038/bjc.1988.143. [DOI] [PMC free article] [PubMed] [Google Scholar]